SCM
MIRM icon

Sterling Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Sterling Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Sell
167
-106
-39% -$10.6K ﹤0.01% 1896
2026
Q1 		$25.2K Buy
273
+2
+0.7% +$188 ﹤0.01% 1918
2025
Q4 		$21.4K Buy
271
+173
+177% +$12.4K ﹤0.01% 2193
2025
Q3 		$7.18K Sell
98
-7
-7% -$445 ﹤0.01% 2644
2025
Q2 		$5.34K Buy
105
+63
+150% +$2.81K ﹤0.01% 2470
2025
Q1 		$1.89K Buy
42
+2
+5% +$94 ﹤0.01% 2623
2024
Q4 		$1.65K Hold
40
– – ﹤0.01% 2829
2024
Q3 		$1.56K Buy
+40
New +$1.6K ﹤0.01% 2311

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sterling Capital Management's MIRM Position: Q2 2026 in Review

Sterling Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 39% in Q2 2026, selling an estimated $10.6K and leaving 167 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1896.

Sterling Capital Management first reported a position in MIRM in Q3 2024 and has held it in 8 quarters since. The position peaked at $25.2K in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Sterling Capital Management held 167 shares of Mirum Pharmaceuticals worth $19.6K as of Q2 2026.
  • Sterling Capital Management sold 106 Mirum Pharmaceuticals shares in Q2 2026, an estimated $10.6K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1896 holding.
  • Sterling Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Mirum Pharmaceuticals position peaked at $25.2K in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.